EDGAR Filing Documents for 0001144204-19-041148

Form SC 13D - General statement of acquisition of beneficial ownership:

SEC Accession No. 0001144204-19-041148

Filing Date

2019-08-22

Accepted

2019-08-22 16:09:02

Documents

Group Members

BAKER BROS. ADVISORS (GP) LLCFELIX J. BAKERJULIAN C. BAKER

Document Format Files

Seq	Description	Document	Type	Size
1	SC 13D	tv528106_sc13d.htm	SC 13D	116131
2	EXHIBIT 99.1	tv528106_ex99-1.htm	EX-99.1	6102
	Complete submission text file	0001144204-19-041148.txt		124055

Mailing Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014

Business Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014 2123395600

BAKER BROS. ADVISORS LP (Filed by) CIK: 0001263508 (see all company filings)

IRS No.: 134093645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030

Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100

BELLICUM PHARMACEUTICALS, INC (Subject) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88493 | Film No.: 191046201
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences